Analysts Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Target Price at $1,008.96
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average rating of “Moderate Buy” from the twenty-two brokerages that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, sixteen have given a buy recommendation and one has given a […]
More Stories
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...